NCT03315975

Flu Vaccine Responses in the Setting of Melanoma Treatment

Influenza Vaccine Responses in the Setting of Melanoma Treatment

• Status: Active Not Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University of Pennsylvania · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.

Detailed description

Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. In particular, immune responses following influenza vaccination have not been studied in the setting of advanced melanoma and in the context of various anti-tumor treatments. In this study, we will look at the immune response of subjects receiving vaccination.

Conditions

• Viral Vaccines

Interventions

Type	Name	Description
BIOLOGICAL	Inactivated influenza vaccine	One dose of quadrivalent inactivated influenza vaccine

Timeline

• Start date: 2017-10-20
• Primary completion: 2026-07-01
• Completion: 2026-07-01
• First posted: 2017-10-20
• Last updated: 2025-08-19

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study